70370-5050 : Crenessity 50 mg Oral Capsule


NDC: 70370-5050
Labeler: Neurocrine Biosciences, Inc.
Product Type: Human Prescription Drug
Drug Name:  Crenessity
Dosage Form: Oral Capsule
Application #: NDA218808
Rev. Date: 


NDC Package Codes:

  • 70370-5050-1: 60 CAPSULE IN 1 BOTTLE (70370‑5050‑1)

Active Ingredients:

  • Crinecerfont

Dosage Strength:

  • 50 mg

Related Products:

Based on records with the same trade name.
  • 70370-5025 Crenessity 25 mg Oral Capsule by Neurocrine Biosciences, Inc.
  • 70370-5100 Crenessity 100 mg Oral Capsule by Neurocrine Biosciences, Inc.
  • 70370-5250 Crenessity 50 mg/ml Oral Solution by Neurocrine Biosciences, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70370-5050 QR Code

< Prev: 70370-5025Next: 70370-5100 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.